A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson Disease

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Boston University Charles River Campus
Study ID
NCT07705373
Status
Recruiting
Apply to this trial

Conditions

  • Parkinson's Disease (PD)

Eligibility Criteria

Sex
ALL
Age
40 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • MR-005 (MedRhythms, Inc., Portland, ME) — DEVICE
    MR-005 (MedRhythms, Inc., Portland, ME) is a personalized, closed-loop, autonomous music-based digital gait intervention designed for self-directed gait training in Parkinson disease (PD). The system uses two shoe-worn gait sensors that communicate in real time with proprietary software on a touchscreen device, which controls the delivery of individualized, progressive rhythmic auditory stimulation (RAS), provided as music cues through bone conduction headphones. The software operates autonomously and does not require manual input or adjustment by the patient or clinician during a session.

Study Details

The purpose of this research study is to examine the effects of a 3-month personalized community-based walking program using a digital music-based device designed for self-directed gait training in people with Parkinson disease (PD). The study uses music cues delivered through this digital device to improve walking outcomes. The investigators want to know if personalized music cueing through the digital device can improve walking quality, walking ability, daily walking amount and intensity, and quality of life, while helping walking feel more automatic and require less mental effort. Participants will take part in this research study for approximately 18 weeks in total. During this time, participants will complete 4 study visits at designated research centers at Boston University, Washington University in St. Louis, or the University of Utah, depending on the site of enrollment.

Key Dates

First listed
Jul 15, 2026
Start date
Aug 20, 2026
Status verified
Aug 2026
Primary completion
Dec 31, 2028
Completion
Feb 28, 2029

Study Design

Enrollment
200 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: MyMusiQ (MMQ) Walking intervention
    Participants use MR-005 (MedRhythms, Inc., Portland, ME) during self-directed, home/community-based walking for 12 weeks to improve walking outcomes.

Primary Outcome Measure

Minutes of Moderate Intensity Walking [ Time Frame: Baseline 1 ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Boston University Center for NeurorehabilitationBostonMassachusetts02215
Erica Clarke, BS
[email protected]
617-358-6157
Terry D. Ellis, PhD, PT (PRINCIPAL_INVESTIGATOR)
Washington University School of MedicineSt LouisMissouri63110
Kayla Bell, PT, DPT
[email protected]
314-273-6016
Kerri Rawson, PhD, MS
[email protected]
813-468-8900
Gammon Earhart, PT, PhD (PRINCIPAL_INVESTIGATOR)
University of UtahSalt Lake CityUtah84108
Rheanna Anderson, MS
[email protected]
801-587-3615
Lee Dibble, PT, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Boston, MA

By research site
Boston University Center for Neurorehabilitation· Boston, MAWashington University School of Medicine· St Louis, MOUniversity of Utah· Salt Lake City, UT

Related Studies